701 related articles for article (PubMed ID: 26590699)
1. α-Glucosidase and α-amylase inhibitors from Myrcia spp.: a stronger alternative to acarbose?
Figueiredo-González M; Grosso C; Valentão P; Andrade PB
J Pharm Biomed Anal; 2016 Jan; 118():322-327. PubMed ID: 26590699
[TBL] [Abstract][Full Text] [Related]
2. The α-amylase and α-glucosidase inhibitory activities of the dichloromethane extracts and constituents of Ferulago bracteata roots.
Karakaya S; Gözcü S; Güvenalp Z; Özbek H; Yuca H; Dursunoğlu B; Kazaz C; Kılıç CS
Pharm Biol; 2018 Dec; 56(1):18-24. PubMed ID: 29233045
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of In Vitro α-Amylase and α-Glucosidase Inhibitory Potentials of 14 Medicinal Plants Constituted in Thai Folk Antidiabetic Formularies.
Somtimuang C; Olatunji OJ; Ovatlarnporn C
Chem Biodivers; 2018 Apr; 15(4):e1800025. PubMed ID: 29460340
[TBL] [Abstract][Full Text] [Related]
4. High-resolution bioactivity profiling combined with HPLC-HRMS-SPE-NMR: α-Glucosidase inhibitors and acetylated ellagic acid rhamnosides from Myrcia palustris DC. (Myrtaceae).
Wubshet SG; Moresco HH; Tahtah Y; Brighente IMC; Staerk D
Phytochemistry; 2015 Aug; 116():246-252. PubMed ID: 25935545
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of black tea and its combination with acarbose on small intestinal α-glucosidase activity.
Satoh T; Igarashi M; Yamada S; Takahashi N; Watanabe K
J Ethnopharmacol; 2015 Feb; 161():147-55. PubMed ID: 25523370
[TBL] [Abstract][Full Text] [Related]
6. Screening for potential α-glucosidase and α-amylase inhibitory constituents from selected Vietnamese plants used to treat type 2 diabetes.
Trinh BTD; Staerk D; Jäger AK
J Ethnopharmacol; 2016 Jun; 186():189-195. PubMed ID: 27041401
[TBL] [Abstract][Full Text] [Related]
7. Isolated compounds from Dracaena angustifolia Roxb and acarbose synergistically/additively inhibit α-glucosidase and α-amylase: an in vitro study.
Yi J; Zhao T; Zhang Y; Tan Y; Han X; Tang Y; Chen G
BMC Complement Med Ther; 2022 Jul; 22(1):177. PubMed ID: 35780093
[TBL] [Abstract][Full Text] [Related]
8. Bioassay-guided fractionation and identification of α-amylase inhibitors from Syzygium cumini leaves.
Poongunran J; Perera HK; Jayasinghe L; Fernando IT; Sivakanesan R; Araya H; Fujimoto Y
Pharm Biol; 2017 Dec; 55(1):206-211. PubMed ID: 27927056
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Total Flavonoids, Myricetin, and Quercetin from Hovenia dulcis Thunb. As Inhibitors of α-Amylase and α-Glucosidase.
Meng Y; Su A; Yuan S; Zhao H; Tan S; Hu C; Deng H; Guo Y
Plant Foods Hum Nutr; 2016 Dec; 71(4):444-449. PubMed ID: 27787697
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Evaluation of a Series of Oleanolic Acid Saponins as α-Glucosidase and α-Amylase Inhibitors.
Guo T; Wu S; Guo S; Bai L; Liu Q; Bai N
Arch Pharm (Weinheim); 2015 Sep; 348(9):615-28. PubMed ID: 26207761
[TBL] [Abstract][Full Text] [Related]
11. Antioxidative activity and inhibition of key enzymes linked to type-2 diabetes (α-glucosidase and α-amylase) by Khaya senegalensis.
Ibrahim MA; Koorbanally NA; Islam MS
Acta Pharm; 2014 Sep; 64(3):311-24. PubMed ID: 25296677
[TBL] [Abstract][Full Text] [Related]
12. In vitro inhibitory activities of selected Australian medicinal plant extracts against protein glycation, angiotensin converting enzyme (ACE) and digestive enzymes linked to type II diabetes.
Deo P; Hewawasam E; Karakoulakis A; Claudie DJ; Nelson R; Simpson BS; Smith NM; Semple SJ
BMC Complement Altern Med; 2016 Nov; 16(1):435. PubMed ID: 27809834
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of α-amylase and α-glucosidase inhibitory potential of Zea mays Linnaeus (Poaceae), Stigma maydis aqueous extract: An in vitro assessment.
Sabiu S; O'Neill FH; Ashafa AOT
J Ethnopharmacol; 2016 May; 183():1-8. PubMed ID: 26902829
[TBL] [Abstract][Full Text] [Related]
14. HPLC-DAD phenolics analysis, α-glucosidase, α-amylase inhibitory, molecular docking and nutritional profiles of Persicaria hydropiper L.
Mahnashi MH; Alqahtani YS; Alyami BA; Alqarni AO; Alqahl SA; Ullah F; Sadiq A; Zeb A; Ghufran M; Kuraev A; Nawaz A; Ayaz M
BMC Complement Med Ther; 2022 Jan; 22(1):26. PubMed ID: 35086537
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of α-glucosidase inhibition by different fractions of three species of Labiatae extracts: a new diabetes treatment model.
Rouzbehan S; Moein S; Homaei A; Moein MR
Pharm Biol; 2017 Dec; 55(1):1483-1488. PubMed ID: 28367665
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory and in silico molecular docking of Xeroderris stuhlmannii (Taub.) Mendonca & E.P. Sousa phytochemical compounds on human α-glucosidases.
Nyathi B; Bvunzawabaya JT; Venissa P Mudawarima C; Manzombe E; Tsotsoro K; Selemani MA; Munyuki G; Rwere F
J Ethnopharmacol; 2023 Aug; 312():116501. PubMed ID: 37100261
[TBL] [Abstract][Full Text] [Related]
17. Chemical constituents from Taraxacum officinale and their α-glucosidase inhibitory activities.
Choi J; Yoon KD; Kim J
Bioorg Med Chem Lett; 2018 Feb; 28(3):476-481. PubMed ID: 29254644
[TBL] [Abstract][Full Text] [Related]
18. α-Glucosidase inhibitory activities of constituents from
Zheng M; Chen S; Liu Y; He Y
Nat Prod Res; 2024 Jun; 38(12):2040-2043. PubMed ID: 37506309
[No Abstract] [Full Text] [Related]
19. α-Glucosidase and α-Amylase Inhibitors from Arcytophyllum thymifolium.
Milella L; Milazzo S; De Leo M; Vera Saltos MB; Faraone I; Tuccinardi T; Lapillo M; De Tommasi N; Braca A
J Nat Prod; 2016 Aug; 79(8):2104-12. PubMed ID: 27509358
[TBL] [Abstract][Full Text] [Related]
20. Screening alpha-glucosidase and alpha-amylase inhibitors from natural compounds by molecular docking in silico.
Jhong CH; Riyaphan J; Lin SH; Chia YC; Weng CF
Biofactors; 2015; 41(4):242-51. PubMed ID: 26154585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
